Endo Voluntarily Recalls Clonazepam: Life-Threatening Mislabeling Concerns
- has announced a voluntary recall of Clonazepam tablets due to serious labeling errors.
- stated, "Our first priority is the quality and safety of our products and the well-being of patients." The company identified this issue through its quality checks.
- Clonazepam, sold under the brand name Klonopin, is a medication used to treat anxiety, prevent seizures, and promote relaxation.
Recall of Clonazepam Tablets: Key Information
Issue Overview
Endo, Inc. has announced a voluntary recall of Clonazepam tablets due to serious labeling errors. The mistake involves cartons showing incorrect strength and National Drug Code (NDC) numbers, which could potentially be life-threatening.
Company Statement
Endo, Inc. stated, “Our first priority is the quality and safety of our products and the well-being of patients.” The company identified this issue through its quality checks.
What is Clonazepam?
Clonazepam, sold under the brand name Klonopin, is a medication used to treat anxiety, prevent seizures, and promote relaxation.
Recalled Product Details
The recall involves Clonazepam packaged in cartons of 60 tablets, divided into 10 blister strips, each containing six tablets. An example of the mislabeling includes a carton showing Clonazepam tablets, USP 1 mg instead of the correct dosage.
Risk Factors
Taking the incorrect dosage of Clonazepam can lead to serious health risks such as:
- Significant sedation
- Confusion
- Dizziness
- Diminished reflexes
- Ataxia (loss of full control of bodily movements)
- Hypotonia (decreased muscle tone)
There is also a significant risk of respiratory depression, especially for patients with existing pulmonary issues or those taking other medications that affect breathing.
What to Do if You Have the Recalled Drug
If you possess any recalled Clonazepam, take these actions:
- Distributors and retailers should stop selling the affected product and return it to the point of purchase.
- Consumers are advised to stop using the product immediately.
- If you think you have taken an incorrect dose, contact your doctor.
Contact Information
For more details about the recall, contact Inmar at 877-890-0765 or email rxrecalls@inmar.com.
Stay informed
For further updates, keep an eye on announcements from Endo, Inc. and the FDA regarding the recall.